Guardian Pharmacy Services (NYSE:GRDN) Reaches New 12-Month High - Still a Buy?

Key Points

• Guardian Pharmacy Services shares reached a new 52-week high of $47.04, up 2.4%, giving the company a market capitalization of approximately $2.37 billion.
• Analyst sentiment remains positive: eight analysts rate the stock a Buy and one rates it Hold, producing a “Moderate Buy” consensus, though the average price target of $43.83 is below the current share price.
• The company exceeded quarterly expectations, reporting $0.29 in EPS versus a $0.26 estimate and revenue of $351.77 million versus $340.45 million. Several institutional investors, including Dimensional Fund Advisors and Bank of America, also increased their holdings.

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) reached a new 52-week high on Tuesday . The company traded as high as $47.04 and last traded at $47.0070, with a volume of 80098 shares trading hands. The stock had previously closed at $46.49.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on GRDN shares. Bank of America boosted their price target on Guardian Pharmacy Services from $42.00 to $47.00 and gave the stock a "buy" rating in a research report on Wednesday, June 17th. Oppenheimer raised their target price on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an "outperform" rating in a research note on Friday, August 7th. Truist Financial boosted their target price on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the stock a "buy" rating in a report on Wednesday, June 17th. Weiss Ratings raised shares of Guardian Pharmacy Services from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Thursday, August 20th. Finally, Wall Street Zen upgraded shares of Guardian Pharmacy Services from a "hold" rating to a "buy" rating in a research note on Sunday, August 9th. Eight equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $43.83.

Guardian Pharmacy Services Trading Up 2.4%

The company has a market capitalization of $2.37 billion, a P/E ratio of 46.43, a P/E/G ratio of 2.26 and a beta of 0.06. The company has a 50 day moving average price of $40.03 and a 200 day moving average price of $38.56.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.26 by $0.03. Guardian Pharmacy Services had a return on equity of 29.97% and a net margin of 4.50%.The business had revenue of $351.77 million during the quarter, compared to the consensus estimate of $340.45 million. As a group, sell-side analysts forecast that Guardian Pharmacy Services, Inc. will post 1.19 EPS for the current fiscal year.

Institutional Trading of Guardian Pharmacy Services

Several hedge funds and other institutional investors have recently modified their holdings of the stock. First Trust Advisors LP bought a new position in shares of Guardian Pharmacy Services during the first quarter worth approximately $3,528,000. Dimensional Fund Advisors LP boosted its stake in Guardian Pharmacy Services by 200.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 208,594 shares of the company's stock valued at $7,855,000 after purchasing an additional 139,070 shares during the period. TimesSquare Capital Management LLC grew its holdings in Guardian Pharmacy Services by 21.9% in the 4th quarter. TimesSquare Capital Management LLC now owns 1,048,136 shares of the company's stock valued at $31,538,000 after buying an additional 187,963 shares in the last quarter. Bank of America Corp DE grew its holdings in Guardian Pharmacy Services by 86.1% in the 1st quarter. Bank of America Corp DE now owns 128,048 shares of the company's stock valued at $4,822,000 after buying an additional 59,245 shares in the last quarter. Finally, Sanctuary Advisors LLC bought a new position in Guardian Pharmacy Services during the 1st quarter worth $1,352,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc is a long-term care pharmacy company that provides prescription medications and related pharmacy services to residents of assisted living communities, skilled nursing facilities, memory care centers and other institutional care settings.

The company's services include medication dispensing and packaging, prescription delivery, medication management, pharmacy consulting and clinical support. Guardian works with care providers, residents and their families to help coordinate medication regimens, improve adherence and support the ongoing pharmacy needs of patients who may require complex or recurring treatments.

Guardian Pharmacy Services operates through a network of community-based pharmacies serving long-term care customers in multiple U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.